BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 1, 2002
View Archived Issues
Centocor’s Remicade Receives Third Rheumatoid Arthritis Nod
Centocor Inc.’s Remicade is inflating - both in uses and sales - having received a third approval in a rheumatoid arthritis indication. (BioWorld Today)
Read More
FDA Panel Agrees To Corixa’s Melacine Phase III Study Protocol
Read More
How Mutated Tumor-Suppressor Gene May Influence Burgeoning Anti-Angiogenic Drug Treatment
Read More
Vasogen CHF Immune Therapy Succeeds In Phase II CHF Study
Read More
Other News To Note
Read More
Gen-Probe, Chiron Gain Approval For HIV, HCV Nucleic Acid Tests
Read More
Appointments And Advancements
Read More